GRDX

GridAI Technologies Corp. NASDAQ Listed Oct 11, 2016

Healthcare ·Biotechnology ·US · grid-ai.com

$2.85

Pre-mkt $3.31 -1.19%

Mkt Cap $9.6M

52w Low $1.06 37.5% of range 52w High $5.84

50d MA $2.29 200d MA $2.98

P/E (TTM) -0.7x

EV/EBITDA -0.6x

P/B 0.2x

Debt/Equity 0.0x

ROE 264.1%

P/FCF -0.9x

RSI (14) —

ATR (14) —

Beta 1.10

50d MA $2.29

200d MA $2.98

Avg Volume 116.4K

GridAI Technologies Corp. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide. The company was founded on January 30, 2014 and is headquartered in Boca Raton, FL.

SIC Code

2834

CIK (SEC)

1604191

Phone

(561) 589-7020

777 Yamato Road · Boca Raton, FL 33431 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 25, 2026	AMC	-11340.00	-2.92	+100.0%	2.69	+0.0%	-10.0%	-5.0%	+16.1%	-4.5%	-2.7%	—
Nov 19, 2025	AMC	—	-0.64	—	3.08	-7.1%	-19.2%	+5.2%	+10.3%	-3.5%	+1.8%	—
Aug 14, 2025	AMC	—	-0.14	—	1.84	-3.3%	-0.5%	+18.0%	-10.6%	+6.7%	-1.5%	—
May 15, 2025	AMC	—	-0.63	—	1.29	+2.3%	-1.6%	-3.1%	+4.9%	-7.8%	+5.0%	—
Apr 4, 2025	AMC	-0.41	-2.61	-536.6%	1.53	-15.7%	-3.9%	-14.3%	+3.2%	-6.9%	-3.3%	—
Nov 13, 2024	AMC	-0.96	-1.32	-37.5%	1.89	-2.1%	-17.5%	-5.8%	-10.2%	-7.6%	-1.6%	—
Aug 26, 2024	AMC	-1.55	-3.84	-147.7%	1.29	+3.1%	+1.6%	-3.8%	-0.8%	-1.6%	+2.4%	—
May 14, 2024	AMC	-2.43	0.38	+115.6%	8.91	-1.7%	-4.7%	+4.6%	+0.7%	-4.4%	+0.4%	—
Feb 27, 2024	AMC	-4.03	-5.35	-32.8%	20.70	-0.7%	+10.1%	+3.8%	+17.1%	-23.9%	+11.1%	—
Sep 30, 2023	AMC	-33.60	-9.08	+73.0%	—	—	—	—	—	—	—	—
Jun 30, 2023	AMC	-20.80	-36.89	-77.4%	96.00	+0.0%	-5.0%	+0.0%	-5.3%	-2.1%	+4.3%	—
Mar 31, 2023	AMC	-43.90	-35.70	+18.7%	160.80	-4.1%	-9.7%	+11.2%	-15.2%	+6.1%	+0.4%	—

Data updated apr 25, 2026 12:17pm · Source: massive.com